Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.25+1.10 (+17.89%)
Close on Nov 13, 2026Market cap $435.76MP/E –Yield –
Orchestra BioMed ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Orchestra BioMed's ebitda for the twelve months ending Sep 30, 2026 was -$60.61M. For fiscal 2025 it was -$51.48M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$51.48M | – |
| FY2024 | Dec 31, 2024 | -$63.99M | – |
| FY2023 | Dec 31, 2023 | -$51.22M | – |
| FY2022 | Dec 31, 2022 | -$32.44M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$23.20M | – |
| Q2 FY2026 | Jun 30, 2026 | -$22.26M | – |
| Q1 FY2026 | Mar 31, 2026 | -$21.99M | – |
| Q4 FY2025 | Dec 31, 2025 | $6.84M | – |
| Q3 FY2025 | Sep 30, 2025 | -$20.23M | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.25M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.84M | – |
| Q4 FY2024 | Dec 31, 2024 | -$16.59M | – |
| Q3 FY2024 | Sep 30, 2024 | -$16.27M | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.79M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.35M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.41M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.45M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.88M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.47M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.76M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.01M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.58M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.08M | – |
See a number that looks wrong?